Author

John Luff

Observed names: J. Luff, John E Luff, John E. Luff, Luff, John

Institution: The University of Queensland

Observed institutions: Griffith University, Queensland University of Technology, The University of Queensland, QIMR Berghofer Medical Research Institute, RIKEN

OpenAlex ID: A5014871649

Senataxin Plays an Essential Role with DNA Damage Response Proteins in Meiotic Recombination and Gene Silencing

2013 · Olivier J. Becherel, Abrey J. Yeo, et al. · PLoS Genetics · 166

PDF

Oxidative Stress Is Responsible for Deficient Survival and Dendritogenesis in Purkinje Neurons from Ataxia-Telangiectasia Mutated Mutant Mice

2003 · Philip Chen, Cheng Peng, et al. · Journal of Neuroscience · 134

PDF

A rat model of ataxia-telangiectasia: evidence for a neurodegenerative phenotype

2016 · Hazel Quek, John Luff, et al. · Human Molecular Genetics · 81

PDF

Dramatic extension of tumor latency and correction of neurobehavioral phenotype in Atm-mutant mice with a nitroxide antioxidant

2006 · Nuri Gueven, John Luff, et al. · Free Radical Biology and Medicine · 68

Smg1 haploinsufficiency predisposes to tumor formation and inflammation

2012 · Tara L. Roberts, Uda Ho, et al. · Proceedings of the National Academy of Sciences · 63

PDF

R-Loops in Proliferating Cells but Not in the Brain: Implications for AOA2 and Other Autosomal Recessive Ataxias

2014 · Abrey J. Yeo, Olivier J. Becherel, et al. · PLoS ONE · 61

PDF

Rats with a missense mutation in Atm display neuroinflammation and neurodegeneration subsequent to accumulation of cytosolic DNA following unrepaired DNA damage

2016 · Hazel Quek, John Luff, et al. · Journal of Leukocyte Biology · 46

PDF

A novel rat model for glioblastoma multiforme using a bioluminescent F98 cell line

2008 · M.J. Bryant, T.L. Chuah, et al. · Journal of Clinical Neuroscience · 44

Senataxin controls meiotic silencing through ATR activation and chromatin remodeling

2015 · Abrey J Yeo, Olivier J Becherel, et al. · Cell Discovery · 43

PDF

Regulation of the Atm promoter in vivo

2005 · Nuri Gueven, Toshiyuki Fukao, et al. · Genes Chromosomes and Cancer · 24

SMG1 heterozygosity exacerbates haematopoietic cancer development in Atm null mice by increasing persistent DNA damage and oxidative stress

2019 · Uda Ho, John Luff, et al. · Journal of Cellular and Molecular Medicine · 9

PDF

Myeloma-Induced Alloreactive T Cells Arising in Myeloma-Infiltrated Bones Include Double-Positive CD8+CD4+ T Cells: Evidence from Myeloma-Bearing Mouse Model

2011 · Lisa M Freeman, Alfred Lam, et al. · The Journal of Immunology · 9

Regulation of RNA degradation pathways during the lipopolysaccharide response in Macrophages

2020 · Hui-Chi Lai, Alexander James, et al. · Journal of Leukocyte Biology · 7

Moderate neuroprotection of combination cell therapy in fetal growth restricted newborns at postnatal day 10

2026 · Kirat K Chand, Kate Beecher, et al. · Stem Cells Translational Medicine

SMG1 is a regulator of toll-like receptor responses

2016 · A. James, John Luff, et al. · European Journal of Immunology

The roles of SMG1 and ATM in stress responses, inflammation and blood cancers

2015 · Tara L. Roberts, Uda Ho, et al. · International Journal of Molecular Medicine

ATM and SMG1 are tumour suppressors which co- regulate blood cancer development and cellular responses to DNA damage and oxidative stress

2015 · Patricia Reberio, Alexander C. James, et al. · Leukemia & lymphoma/Leukemia and lymphoma

Depletion of Host CD122+ Cells Facilitates Widespread Skeletal Multiple Myeloma Engraftment in NOD/SCID Recipients

2008 · Lisa M Freeman, Eugene Petcu, et al. · Blood

Generation of an ATM knock in mouse with the breast-cancer susceptibility mutation, 7271T>G

2006 · Jeremy M. Arnold, Jean S. Fleming, et al.

Works count: 20

Citation count: 755

H-index: 10

I10-index: 10